Cargando…

An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder

Overactive bladder is a common and bothersome condition. Antimuscarinic agents, as a class, are the cornerstone of medical treatment of overactive bladder. They offer significant improvements in symptoms and patients' quality of life. Antimuscarinics are generally well tolerated with mild and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Athanasopoulos, Anastasios, Giannitsas, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114080/
https://www.ncbi.nlm.nih.gov/pubmed/21687579
http://dx.doi.org/10.1155/2011/820816
_version_ 1782206026278240256
author Athanasopoulos, Anastasios
Giannitsas, Konstantinos
author_facet Athanasopoulos, Anastasios
Giannitsas, Konstantinos
author_sort Athanasopoulos, Anastasios
collection PubMed
description Overactive bladder is a common and bothersome condition. Antimuscarinic agents, as a class, are the cornerstone of medical treatment of overactive bladder. They offer significant improvements in symptoms and patients' quality of life. Antimuscarinics are generally well tolerated with mild and predictable side effects. Available antimuscarinics have small, yet statistically significant, differences in their efficacy and tolerability profiles. In clinical practice, finding the agent that offers the optimum balance of efficacy and side effects for an individual patient remains the major challenge.
format Online
Article
Text
id pubmed-3114080
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-31140802011-06-17 An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder Athanasopoulos, Anastasios Giannitsas, Konstantinos Adv Urol Review Article Overactive bladder is a common and bothersome condition. Antimuscarinic agents, as a class, are the cornerstone of medical treatment of overactive bladder. They offer significant improvements in symptoms and patients' quality of life. Antimuscarinics are generally well tolerated with mild and predictable side effects. Available antimuscarinics have small, yet statistically significant, differences in their efficacy and tolerability profiles. In clinical practice, finding the agent that offers the optimum balance of efficacy and side effects for an individual patient remains the major challenge. Hindawi Publishing Corporation 2011 2011-06-07 /pmc/articles/PMC3114080/ /pubmed/21687579 http://dx.doi.org/10.1155/2011/820816 Text en Copyright © 2011 A. Athanasopoulos and K. Giannitsas. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Athanasopoulos, Anastasios
Giannitsas, Konstantinos
An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
title An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
title_full An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
title_fullStr An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
title_full_unstemmed An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
title_short An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
title_sort overview of the clinical use of antimuscarinics in the treatment of overactive bladder
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114080/
https://www.ncbi.nlm.nih.gov/pubmed/21687579
http://dx.doi.org/10.1155/2011/820816
work_keys_str_mv AT athanasopoulosanastasios anoverviewoftheclinicaluseofantimuscarinicsinthetreatmentofoveractivebladder
AT giannitsaskonstantinos anoverviewoftheclinicaluseofantimuscarinicsinthetreatmentofoveractivebladder
AT athanasopoulosanastasios overviewoftheclinicaluseofantimuscarinicsinthetreatmentofoveractivebladder
AT giannitsaskonstantinos overviewoftheclinicaluseofantimuscarinicsinthetreatmentofoveractivebladder